APRE: $30 from $15 | a risk free deal

Mis à jour
ahead of the curve going all in
Note
it came back to where it started and even way lower
and reversed backed.

cycle
Beyond Technical AnalysisbiotechcoronaCoronavirus (COVID-19)novelpharmaceuticals

Clause de non-responsabilité